Categories: News

Aleafia Health Launches Sunday Market™ House of Brands

The Sunday Market house of brands

Aleafia Health Inc.

TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its new Canadian cannabis portfolio Sunday MarketTM. Under the Sunday Market family are four new distinct brands, each tailored to a specific consumer segment and featuring its own roster of cannabis products.

The four brands will be launched in the adult-use market, with some formats also being made available to patients of Aleafia Health’s medical cannabis subsidiary, Emblem. They will complement Aleafia Health’s existing Symbl adult-use brand and Kin Slips sublingual strips line of products.

“The Sunday Market house of brands has been crafted to provide consumers with a welcoming, authentic experience that showcases the local community and the people that create great cannabis products,” said Tricia Symmes, Aleafia Health’s chief commercial officer. “Our well-earned reputation for product quality and excellence serves as the foundation for the launch of these new highly differentiated brands and an expanding product portfolio.”

  • Nith & Grand: The flagship brand’s namesake is a tribute to our product innovation facility’s home community of Paris, Ont., whose scenic downtown core is centred around the confluence of the Nith and Grand rivers. Featuring hang dried, hand trimmed, small batch dried flower, and premium concentrates, Nith & Grand appeals to cannabis aficionados with discerning tastes. First products launch in Q2 2021.
  • Bogart’s Kitchen: An edible cannabis brand, Bogart’s Kitchen combines extensive R&D and culinary experimentation to provide novice and high frequency cannabis consumers with a craveable experience. It will feature high demand formats including soft chews, along with some novel edibles not yet available in Canada. First products will appear in Q1 2021.
  • Divvy: The friendly, everyday cannabis brand, Divvy will feature affordable, high-quality, dried flower, pre-rolls, vape cartridges and concentrates, including larger format SKUs. First products are expected to appear in Q1 or early Q2 2021.
  • Noon & Night: The trailblazing Noon & Night is a cannabis wellness brand, catering to the growing demand for CBD-dominant products in both traditional CPG and other more innovative formats. It will feature innovative formats that are already an important component of consumers’ everyday wellness routine. First products launching in Q2 2021.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f3f96285-4235-48ca-b8fb-d3b1830eaae9

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Staff

Recent Posts

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"…

1 hour ago

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co.,…

8 hours ago

Casect Launches AI-Enhanced Case Log Platform for Surgeons

SHERIDAN, Wyo., Dec 25, 2024 /PRNewswire/ -- Casect, LLC, a medical education technology company, announces…

14 hours ago

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced…

23 hours ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be…

23 hours ago